RheumJC4 Part 2: Tapering Biologics--Why, How, and What If

Part 2 of our slide show summarizing the latest conversation of the Twitter-based rheumatology journal club #rheumjc looks into tapering of biologics for rheumatoid arthritis in actual practice.Three of the participating rheumatologists practice outside the United States, offering a noteworthy difference of perspective.The discussion in Part 1 focused on a randomized trial of biologic tapering published recently in BMJ. Here, participants focused on the clinical realities: Why to taper, whom to taper, when to start tapering, how to decide whether restarting the biologic is warranted, and what happens next.